Drug Type Therapeutic vaccine |
Synonyms CYT003-QbG10 + approved allergan extract, CYT003-QbG10 combination vaccine, CYT005-ALLQBG10 |
Target |
Mechanism TLR9 agonists(Toll like receptor 9 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rhinoconjunctivitis | Phase 2 | CH | 01 Feb 2006 | |
Allergic rhinoconjunctivitis | Phase 2 | CH | 01 Mar 2005 | |
House dust mite allergy | Phase 2 | CH | 01 Mar 2005 | |
Perennial allergic conjunctivitis | Phase 2 | CH | 01 Mar 2005 | |
Allergic asthma | Phase 2 | CH | - | |
Asthma | Phase 2 | - | - | |
Conjunctivitis, Allergic | Phase 2 | CH | - | |
Conjunctivitis, Allergic | Phase 2 | - | - | |
Rhinitis, Allergic, Perennial | Phase 2 | CH | - | |
Rhinitis, Allergic, Perennial | Phase 2 | - | - |